Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

tim_de_gavre

Head of Sandoz UK becomes BGMA chair

May 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sandoz, appointment, bgma, pharma

Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
Appointment

Staff shortfall leads to massive deficit for NHS

May 31, 2018 Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …
News
allergan-westport-ireland_web

Allergan aims to appease investors with non-core units sell off

May 31, 2018 Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical

Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …
News
pharmafocus_june_2018_cover

The June 2018 issue of Pharmafocus is now live!

May 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma

The new June edition of Pharmafocus is now available to read online.
News

Insider Interview: Gilead’s fight against HIV comes into bloom

May 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, Insider Interview, pharma

Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …
Feature

Envision Pharma Group supports Otsuka’s medical affairs activities

May 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Envision Pharma Group

Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities. Otsuka Pharmaceutical Development …
News
Press release

NHS England uses £10m fund to retain GPs

May 30, 2018 Medical Communications, Research and Development GP, NHS, UK government, biotech, drugs, pharma, pharmaceutical

On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …
News
novato-south-campus

BioMarin receives FDA nod for its would-be blockbuster

May 25, 2018 Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical

BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
News

AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer

May 25, 2018 Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …
News
breast_cancer_scan

Breast cancer screening scandal potentially involves even more women

May 25, 2018 Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

The news broke at the start of the month that a number of women who should have been invited to …
News
prothena-37882-2

Prothena guts workforce by more than half, after trial failure

May 25, 2018 Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical

Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …
News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Feature
astellas_tokyo_copy

Astellas begins major restructure, as 600 jobs slashed

May 24, 2018 Medical Communications Astellas, biotech, drugs, pharma, pharmaceutical

Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …
News
nhs_parliament_2_4

Report calls for tax rises to fund ailing NHS

May 24, 2018 Medical Communications IFS, NHS, UK government, biotech, drugs, pharma, pharmaceutical

A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026